News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
16 | Follower
Hospital and health system M&A ticked up slightly from the first quarter, but was still low compared to past years. Medicaid cuts, tariffs and market volatility have dampened M&A activity this year, according to Kaufman Hall.
The HHS wants to move oversight of the controversial drug discount program to the CMS, which has a more aggressive history with 340B than its covered providers would prefer. “It could be truly devastating,” one expert said.
Many popular proposals to reform the PBM industry are missing the forest for the trees, drug market experts said this week in Washington, D.C. Instead, Congress should go after the root issue: the oligopoly enjoyed by the Big Three PBMs.